US Patent 6977080 Intrapericardial botulinum toxin treatment for bradycardia
Patent 6977080 was granted and assigned to Allergan, Inc. on December, 2005 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 10, 1999
0
Date of Patent
December 20, 2005
0
Patent Application Number
09371354
0
Patent Inventor Names
Stephen Donovan
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 6977080 Intrapericardial botulinum toxin treatment for bradycardia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.